טוען...
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib monotherapy was previously shown to inhibit structural damage, reduce clinical signs and symptoms of RA, and improve physical functioning over 24 months in methotrexate (MTX)-naive...
שמור ב:
| הוצא לאור ב: | RMD Open |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4964179/ https://ncbi.nlm.nih.gov/pubmed/27493790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2016-000262 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|